Get started

Hotstocks

NIO - Low Valuation Compared to TeslaNIO Limited designs, manufactures, and sells electric vehicles in the People's Republic of China, Hong Kong, the United States, the United Kingdom, and Germany. The company offers five, six, and seven-seater electric SUVs. It is also involved in the provision of energy and service packages to its users; marketing, design, and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. In addition, the company offers charging solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Mobile, a mobile charging service through charging trucks; Public Charger, a public fast charging solution; and Power Express, a 24-hour on-demand pick-up and drop-off charging service. Further, it provides value-added services, such as statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance services; courtesy car services during lengthy repairs and maintenance; and roadside assistance, as well as data packages. NIO Limited has a strategic collaboration with Mobileye N.V. for the development of automated and autonomous vehicles; and collaboration agreements with various manufacturers for the manufacture of ES8, a six or seven-seater high-performance electric SUV. The company was formerly known as NextEV Inc. and changed its name to NIO Limited in July 2017. NIO Limited was founded in 2014 and is headquartered in Shanghai, China. NIO, which was founded in 2014, currently offers two premium electric SUVs ES8 and ES6, which are priced starting at about $51k. The company is also innovating in the self-driving technology space and offers a battery swap service. Nio delivered 20,565 cars last year, marking an 81% year-over-year increase. NIO is growing faster than Tesla due in part to the large China population. While NIO is in the earlier phases of growth with revenue expanding 56% last year and growth likely to accelerate in 2020, Tesla sales grew by just 15% last year and could potentially slow in 2020. Overall, compared to Tesla, NIO’s has a faster growth ratio and lower valuation multiple which makes a case for the stock. So, at its current price, NIO is in my opinion a buy. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NIOLong
by HotCharts
Bullish Sector - 5G Play, Golden CrossNokia Corporation engages in the network and technology businesses worldwide. The company operates in four segments: Ultra Broadband Networks, Global Services, IP Networks and Applications, and Nokia Technologies. It focuses on mobile radio including macro radio, small cells, and cloud native radio solutions for communications service providers and enterprises; and provides network planning and optimization, network implementation, and systems integration, as well as company-wide managed services. The company also offers fixed networking solutions, such as copper and fiber access products, solutions, and services. In addition, it provides network infrastructure and professional services for mobile networks; and managed services for the fixed, mobile, Internet protocol (IP), and optical domains. Further, the company offers network planning, implementation, operation, and maintenance services. Additionally, it provides IP/optical networking solutions, including IP routing and optical transport systems, software, and services; software solutions, such as customer experience management, network operations and management, communications and collaborations, policy and charging, as well as Cloud, IoT, security, and analytics platforms; and submarine networks and radio frequency systems. The company has a strategic collaboration with Microsoft. Nokia Corporation was founded in 1865 and is headquartered in Espoo, Finland. Nokia continues receiving 5G contracts. On the Daily Chart, the 50-Day MA is ready to Cross up and over the 200-Day MA, Bullish I think NOK has a shot at reversing its downward trend real soon especially if the USA takes an ownership in the company like many White House officials have been talking about possibly doing to stop China. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NYSE:NOKLong
by HotCharts
1
Merger Approved - Huge Drug Company & Dirt Cheap Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded-generic, brand-name, and over-the-counter (OTC) pharmaceutical products in North America, Europe, and internationally. It offers active pharmaceutical ingredients and finished dosage forms; and antiretroviral medicines to treat HIV/AIDS. The company also provides prescription products, such as EpiPen Auto-Injector; Perforomist Inhalation Solution; Dymista; Creon; and Influvac, as well as YUPELRI, an inhalation solution for the maintenance treatment of patients with chronic obstructive pulmonary diseases. In addition, it markets OTC products, including Cold-EEZE, MidNite, Vivarin, Brufen, CB12, and EndWarts. The company offers its products to therapeutic areas, such as cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, gastroenterology, immunology, infectious disease, oncology, respiratory and allergy, and women's health. Its customers include retail pharmacies, wholesalers and distributors, payers, and insurers and governments, as well as institutions, such as hospitals. Mylan N.V. has collaboration and license agreements with Pfizer Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; Fujifilm Kyowa Kirin Biologics Co. Ltd; and Revance Therapeutics, Inc. The company was founded in 1961 and is based in Hatfield, the United Kingdom. Today, news that the merger with Upjohn was approved hit the news wires. www.bizjournals.com Mylan is in my opinion, one of the cheapest drug stocks in the sector at current levels. The stock currently trades at only 4x projected 2020 and 2021 earnings. The stock should be upwards of $25 to $30 a share with the merger approval. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
MLong
by HotCharts
Bullish Charts - Above the Cloud, Ready to Spike, Zika VirusBioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, ALPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. It is also developing BCX7353, an oral serine protease inhibitor and oral dose formulation that is in Phase III clinical trials to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in preclinical trials to treat fibrodysplasia ossificans progressive; and Galidesivir, an RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with U.S. Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina. Daily Chart: Volume: Bullish PMO Turning Up, Bullish MACD Turning Up, Bullish RSI: Bullish Stochastic: Bullish OBV: Bullish Accumulation: Bullish Sector: Bullish Closed above the cloud on Friday - Bullish On 06/10/2020, Company reported Galidesivir stopped the Zika virus replication. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:BCRXLong
by HotCharts
NKLA Announces Joint Venture with CNH Industrial This is a follow-up to my previous posts. Today, Nikola announced the joint venture with CNH Industrial that I have been talking about for several weeks. Why this stock is not moving way up on all the great news is beyond my understanding. The IVECO unit of CNH Industrial has been building big rigs for decades, and will jointly start building the Tre in Germany with Nikola. Nikola Tre Featured snippet from the web The battery electric NIKOLA TRE is based on the IVECO S-WAY and integrates NIKOLA's class-leading technology. It is the first step on the path towards the fuel cell electric model (FCEV). Dec 6, 2019 www.caranddriver.com Nikola also announced it has $12 billion in pre-orders for its U.S. trucks, up from the previous $11 billion. www.bizjournals.com In a report by Cowen & Co. on June 17, 2020, the report essentially said, "by Nikola outsourcing production, it could mitigate risks that Tesla went through." CNH is Nikola's partner in the venture. Is there something someone on Wall Street does not understand? CNH owns over 25 million shares of Nikola or 7.11%. CNH has a market cap of almost $10 Billion. While investors are buying up stocks like Workhorse Group, buying on speculation, you have a company here, CNH Industrial, already making billions of dollars aside from the electric vehicles. This is the stock to own in my opinion. It's all about common sense and profits. CNH is already profitable so going into a joint venture with Nikola will just add more revenue to the company. In the link below, CNH is mentioned in the paragraph after the chart. None of the news wires posted the link below to Wall Street news services today. It leaves me thinking, are people secretly buying up CNH before they run it up to $20.00 or $50.00 like they have done with several stocks in the electric vehicle industry? www.bloombergquint.com DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
CLong
by HotCharts
COVID-19 Vaccine, 1st Effective Drug, USA Secures 500,000 DosesHHS secures 500,000 doses of remdesivir. The Trump administration has secured 500,000 doses of remdesivir, the first drug shown to be effective at treating hospitalized coronavirus patients, ensuring these doses will be for U.S. use. This could mean huge profits for GILD. Indicators are starting to turn up, Bullish. Daily Chart is turning Bullish. I think if the stock breaks above the $77.00 range, it's going to spike. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:GILDLong
by HotCharts
4
Bullish Charts - Golden Cross, Buyout TargetSprouts Farmers Market, Inc., a healthy grocery store, provides fresh, natural, and organic food products in the United States. Its stores offer fresh produce, packaged groceries, meat and seafood, deli, vitamins and supplements, dairy and dairy alternatives, bulk items, baked goods, frozen foods, natural health and body care, beer and wine, and household items. As of February 20, 2020, it operated 341 stores in 22 states. Sprouts Farmers Market, Inc. was founded in 2002 and is based in Phoenix, Arizona. Daily Chart: Volume: Bullish PMO Turning Up: Bullish MACD Turning Up: Bullish RSI: Bullish Stochastic: Bullish OBV: Bullish Accumulation: Bullish Sector: Bullish 100-Day MA just crossed the 200-Day MA - Bullish Market got crushed today, Sprouts was up. Bullish I personally think Sprouts could be a buyout target especially after Amazon bought Whole Foods. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:SFMLong
by HotCharts
Bullish Charts - Golden Cross, Possible BuyoutCloudera, Inc. provides a suite of data analytics and management products in the United States, Europe, and Asia. The company operates through two segments, Subscription and Services. It offers Cloudera Enterprise Data Hub that allows companies to execute various analytic functions against a shared set of governed and secures data in public and private clouds, and data centers; Cloudera Data Warehouse, a hybrid cloud solution for self-service analytics; Cloudera Data Science and Engineering enables users to streamline, simplify, and scale big data processing; and Cloudera Operational DB that enables stream processing and real-time analytics on continuously changing data. The company also provides Hortonworks Data Platform, a data management platform that helps organizations to securely store, process, and analyze various data assets; Cloudera DataFlow, a data platform that collects, curates and analyzes data; Cloudera Data Science Workbench that enables self-service data science for the enterprise; and Cloudera Altus, a platform-as-a-service offering In addition, it offers Cloudera SDX, a solution that enables common security, governance, lineage, and metadata management for multiple analytics functions; and Cloudera Workload XM, an analytic workload experience management cloud service. Further, the company provides consulting, professional, and education services. It serves corporate enterprises and public sector organizations primarily through its direct sales force. The company was founded in 2008 and is headquartered in Palo Alto, California. Daily Chart: Volume: Bullish PMO: Bullish MACD: Bullish RSI: Bullish Stochastic: Bullish OBV: Bullish Accumulation: Bullish Sector: Bullish 50-Day MA just crossed the 100-Day MA and the 200-Day MA - Bullish Search through the recent news, there has been a lot of talk about Cloudera being bought for as high as $18.00 a share. IBM was mentioned as a potential buyer of the company. Market got crushed today, Cloudera was up. - Bullish Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
CLong
by HotCharts
Bullish Charts - In-Home COVID-19 TestCo-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah. Daily Chart MACD, RSI & STOCHASTIC are turning up, Bullish Volume is also picking up steam. On 06/09/2020, CODX announced the company will be added to the Russell 2000 and 3000 Indexes On 05/28/2020, Analysts set price targets at $30 and $36 On 05/26/2020, CODX said its Logix Smart Covid-19 test kit was used to demonstrate that the SARS-CoV-2 virus can be detected in cancer tissue of coronavirus patients. On 05/18/2020, Price Target Raised to $35.00 The stock looks like it's on the verge of breaking out much higher. Long! DISCLAIMER The Content herein is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
NASDAQ:CODXLong
by HotCharts